Salute e Benessere

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 8 November 2024– This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and...
Nasdaq GlobeNewswire
08/11/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 8 November 2024– The execution of Novo Nordisk A/S' overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 3,136,206,122.30 in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules”).The purpose of the...
Nasdaq GlobeNewswire
08/11/2024

Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings…

Bagsværd, Denmark, 8 November 2024– Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 4,736,088,225.00 from Novo Holdings A/S. The transaction is part of Novo Nordisk A/S' 2024 share repurchase programme of up to a total of DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. The transaction price is DKK 750.42 per share and has been calculated as the three-day volume weighted average market price...
Nasdaq GlobeNewswire
08/11/2024

Global Infusion Pumps Market Projected to Reach $14.7 Billion by 2029

This report provides an in-depth analysis of the infusion pump market, including the market shares of leading companies. The market is segmented by product types, including general-purpose infusion pumps, such as large-volume, syringe, electronic ambulatory, and elastomeric pumps, as well as specialty pumps such as insulin, patient-controlled analgesia, enteral, and implantable infusion pumps. The report focuses on application areas such as diabetes management, pain management/analgesia…
PR Newswire
08/11/2024

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of October 31, 2024(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Paris, France (November 8, 2024 - 6:00 pm)– As of October 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down...
Nasdaq GlobeNewswire
08/11/2024

Monthly information related to total number of voting rights and shares…

Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2024 Article 223-16 of general regulation of French Autorité des Marchés FinanciersListing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)Website : www.phaxiam.com DateTotal of shares composing the share capitalTotal of brut(1)voting rightsTotal of net(2)voting rights December 31, 20236...
Nasdaq GlobeNewswire
08/11/2024

Medical Device Packaging Market Poised for Significant Expansion, Projected to…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1062219 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1062219 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Medical Device Packaging Market Overview Market Size and Growth The Medical Device Packaging Market is experiencing significant growth, projected to expand from approximatelyUSD 37.4 billionin 2024 toUSD 56.1 billion...
PR Newswire
08/11/2024

Physiotherapy Equipment Market to Hit USD 27.03 Billion by 2029 with 6.1% CAGR |…

Browse in-depth TOC on "Physiotherapy Equipment Market" Browse in-depth TOC on "Physiotherapy Equipment Market" 173 - Tables40 - Figures250 - Pages By product,the physiotherapy equipment market is segmented into equipment and accessories. In 2023, the equipment segment accounted for largest share in the physiotherapy equipment market due to essential role of physiotherapy equipment's in rehabilitative care. The demand for physiotherapy equipment such as electrotherapy,...
PR Newswire
08/11/2024

TESTCARD TEST KIT: GROUNDBREAKING NEW TRIAL FOR PROSTATE CANCER SCREENING IN THE…

Historically, prostate cancer screening has required patients to travel to a clinic for a blood test and then travel again to receive their results. These friction points during screening can cause patients to put off their appointments or not to attend at all. Historically, prostate cancer screening has required patients to travel to a clinic for a blood test and then travel again to receive their results. These friction points during screening can cause patients to put off their…
PR Newswire
08/11/2024

Anesthesia Monitoring Devices Market is expected to generate a revenue of USD…

The healthcare industry faces increasing pressure to deliver precision care, with anesthesia monitoring devices at the core of safe and effective patient management. Our research identifies the market's key growth drivers, from technological advancements in sensor technology to the rising adoption of minimally invasive surgeries. This report will equip decision-makers with the knowledge needed to capitalize on emerging trends and address the challenges of regulatory compliance and technological…
PR Newswire
08/11/2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 8 November 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
08/11/2024

Director/PDMR Shareholding

DXS INTERNATIONAL PLC(AQSE: DXSP)Notification of Director / PDMR DealingDXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 6 November 2024 Mr Bob Sutcliffe, the Chairman, purchased a total of 35,000 Ordinary Shares in the Company at a price of 1.3p per share. Following this transaction Mr...
Nasdaq GlobeNewswire
08/11/2024

Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio…

BOSTON and LONDON, Nov.08, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces shareholder approval in connection with the merger of Akari Therapeutics, Plc (the Company) and Peak Bio, Inc. At a General Meeting held in relation to the merger at 9:00 a.m. Eastern Time on Thursday, November 7, 2024 at the Company's offices in London, shareholders approved the...
Nasdaq GlobeNewswire
08/11/2024

Notification of managers' transactions

ANNOUNCEMENT NO. 284 8 November 2024 Notification of managers' transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.See the transactions of the Vice Chair of ChemoMetec's Board of Directors Martin Glensbjerg in the attached PDF document.For further...
Nasdaq GlobeNewswire
08/11/2024

Notification of managers' transactions

ANNOUNCEMENT NO. 283 8 November 2024 Notification of managers' transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.See the transactions of the CEO Martin Helbo Behrens in the attached PDF document.For further information, please contact:Kim...
Nasdaq GlobeNewswire
08/11/2024

Step up, show up: Dubai's annual walkathon WeWalk returns in fight against…

His Excellency Ahmed Al Suwaidi, CEO of Dubai Charity Association, said: "We at Dubai Charity Association are pleased to cooperate with TECOM Group PJSC in organising the fifth edition of our annual charity event WeWalk, which mirrors the key pillars of our strategy and corporate values. Dubai Charity Association has always been keen on promoting charitable work and fostering social cohesion and human interaction amongst various segments of society, in line with our visionary leadership's…
PR Newswire
08/11/2024

RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 -…

Consolidated net revenue of € 1,743.1 million in the first nine months, +12.0% or +9.3% on a like-for-like basis (3)and at constant exchange rates (CER)EBITDA (1)of € 665.7 million, +11.8%, revenue margin of 38.2% Adjusted net income (2)of € 445.4 million, +9.5%Net income of € 338.4 million, +11.1%Free cash flow (4)at € 434.3 million, +€ 42.5 million vs prior yearNet debt (5)at € 1,317.3 million, just below 1.6x EBITDA...
Nasdaq GlobeNewswire
08/11/2024

Implantica presents the third quarter 2024 on November 15 at 15:00 CEST

If you wish to participate via webcast, please use the following link: If you wish to participate via webcast, please use the following link: If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference. Speakers: For further information, please contact: Nicole Pehrsson, Investor Relations Telephone (CH): +41 (0)79 335 09 49nicole.pehrsson@implantica...
PR Newswire
08/11/2024

Coway Announces Financial Results for Q3 FY2024

Coway's reported earnings are as follows: Coway's reported earnings are as follows: * The reported figures are taken from the consolidated K-IFRS (International Financial Reporting Standards) statement. Cumulative revenue for 2024 now stands atKRW 3,184.4billion (+7.5% YoY) with an operating profit of KRW 612.0 billion (+8.3% YoY). InSouth Korea, domestic business generatedKRW 660.8 billionin revenue for the third quarter, up 9.9% from last year. This increase has been...
PR Newswire
08/11/2024

Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC…

Jonathan Kwok, Chief Executive Officer & Co-Founder at Infinitopes, said: "Using our integrated 'right targets, right vectors, right patients, right time' approach, we aim to address the unmet clinical need for durably effective, accessible therapies, to save lives by preventing or significantly delaying disease recurrence for cancer patients. We combine our deep knowledge of the field of immunology with our uniquely sensitive AI/ML Precision ImmunomicsTM platform to identify and select…
PR Newswire
08/11/2024

'ESSE' Maker KT&G Expands Presence in Europe with Romania Entry, Achieving…

In the third quarter, the growth of the main business centered on the tobacco sector continued. In particular, the growth of the overseas cigarette business stood out. In the third quarter, revenue of the overseas cigarette business reached KRW 419.7 billion, up 30.5% year-over-year, setting a new record in revenue for two consecutive quarters, while sales volume and operating profit also increased by 10.1% and 167.2%, respectively, achieving "growth trifecta" in sales volume, revenue…
PR Newswire
08/11/2024

Fapon Highlights Innovative IVD Total Solutions and Localization Services at…

At the exhibition, Fapon will present a suite of total solutions across various technology applications, including CLIA, biochemistry, NGS, PCR, LFA and FIA for both clinical diagnostic labs and POCT scenarios. Leveraging its strong foundation in IVD technologies, Fapon integrates raw materials, reagent services, and open-system instruments into IVD total solutions. This approach ensures reliable, versatile, and seamless services for our IVD partners, particularly local IVD companies and…
PR Newswire
08/11/2024

Eisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025)…

BioArctic's report for the third quarter 2024 will be published on November 14 at 08.00 a.m. CET. BioArctic's report for the third quarter 2024 will be published onNovember 14at08.00 a.m. CET. This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact person below, onNovember 8, 2024, at05.00 a.m. CET. For...
PR Newswire
08/11/2024

Global Respiratory Disease Testing Market to Grow at a CAGR of ~4% by 2030 |…

Key Takeaways from the Respiratory Disease Testing Market Report Key Takeaways from the Respiratory Disease Testing Market Report To read more about the latest highlights related to the respiratory disease testing market, get a snapshot of the key highlights entailed in the Global Respiratory Disease Testing Market Report Respiratory Disease Testing Overview Respiratory disease testing is a critical aspect of diagnosing and managing various conditions that affect the lungs and...
PR Newswire
07/11/2024
Altri  Comunicati